Dna Brands Stock Performance
| DNAX Stock | USD 0.0001 0.0001 50.00% |
DNA Brands holds a performance score of 11 on a scale of zero to a hundred. The firm owns a Beta (Systematic Risk) of 3.71, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, DNA Brands will likely underperform. Use DNA Brands coefficient of variation, semi variance, relative strength index, as well as the relationship between the treynor ratio and rate of daily change , to analyze future returns on DNA Brands.
Risk-Adjusted Performance
11 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in DNA Brands are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, DNA Brands showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Price Earnings Ratio | 0.15 | |
| Total Cashflows From Investing Activities | 1000 K |
DNA |
DNA Brands Relative Risk vs. Return Landscape
If you would invest 0.02 in DNA Brands on August 27, 2024 and sell it today you would lose (0.01) from holding DNA Brands or give up 50.0% of portfolio value over 90 days. DNA Brands is currently generating 6.1538% in daily expected returns and assumes 41.9334% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than DNA, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
DNA Brands Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for DNA Brands' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as DNA Brands, and traders can use it to determine the average amount a DNA Brands' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1468
| Best Portfolio | Best Equity | DNAX | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 41.93 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average DNA Brands is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DNA Brands by adding it to a well-diversified portfolio.
DNA Brands Fundamentals Growth
DNA Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of DNA Brands, and DNA Brands fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on DNA Pink Sheet performance.
| Operating Margin | (0.98) % | |||
| Current Valuation | 1.47 M | |||
| Shares Outstanding | 22.07 K | |||
| Price To Earning | 0.20 X | |||
| Price To Sales | 0.11 X | |||
| Revenue | 249.01 K | |||
| EBITDA | (239.66 K) | |||
| Cash And Equivalents | 499 | |||
| Total Debt | 2 M | |||
| Book Value Per Share | (0.92) X | |||
| Cash Flow From Operations | (1.1 M) | |||
| Earnings Per Share | 0.02 X | |||
| Total Asset | 327 K | |||
| Retained Earnings | (30.44 M) | |||
| Current Asset | 319 K | |||
| Current Liabilities | 3.43 M |
About DNA Brands Performance
Evaluating DNA Brands' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if DNA Brands has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if DNA Brands has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
It offers products in various flavors, such as cellular citrus zero sugar, cellular citrus, cryo berry, and molecular melon. DNA Brands, Inc. also owns TokenTalk.io, an advisory firm for companies looking to raise money through an ICO. Dna Brands operates under BeveragesNon-Alcoholic classification in the United States and is traded on OTC Exchange. It employs 1 people.Things to note about DNA Brands performance evaluation
Checking the ongoing alerts about DNA Brands for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for DNA Brands help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| DNA Brands is way too risky over 90 days horizon | |
| DNA Brands has some characteristics of a very speculative penny stock | |
| DNA Brands appears to be risky and price may revert if volatility continues | |
| DNA Brands currently holds 2 M in liabilities. DNA Brands has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist DNA Brands until it has trouble settling it off, either with new capital or with free cash flow. So, DNA Brands' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DNA Brands sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DNA to invest in growth at high rates of return. When we think about DNA Brands' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 249.01 K. Net Loss for the year was (1.25 M) with profit before overhead, payroll, taxes, and interest of 249.01 K. | |
| DNA Brands currently holds about 499 in cash with (1.1 M) of positive cash flow from operations. |
- Analyzing DNA Brands' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DNA Brands' stock is overvalued or undervalued compared to its peers.
- Examining DNA Brands' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating DNA Brands' management team can have a significant impact on its success or failure. Reviewing the track record and experience of DNA Brands' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of DNA Brands' pink sheet. These opinions can provide insight into DNA Brands' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for DNA Pink Sheet Analysis
When running DNA Brands' price analysis, check to measure DNA Brands' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNA Brands is operating at the current time. Most of DNA Brands' value examination focuses on studying past and present price action to predict the probability of DNA Brands' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNA Brands' price. Additionally, you may evaluate how the addition of DNA Brands to your portfolios can decrease your overall portfolio volatility.